The in vitro experiments demonstrated that CMTM4 exhibited antitumourigenic activities in ccRCC; therefore, we subsequently used a xenograft model in nude mice to confirm the ex vivo tumour-suppressor activity of CMTM4. The gene discussed is CMTM4; the disease is nonpapillary renal cell carcinoma.